InvestorsHub Logo
Followers 8
Posts 303
Boards Moderated 0
Alias Born 01/02/2018

Re: None

Tuesday, 01/28/2020 8:46:21 AM

Tuesday, January 28, 2020 8:46:21 AM

Post# of 35961

Research member of Inspyr Therapeutics, Søren Brøgger Christensen.

Still investigating and publishing 1/27/2020 information on Thapsigargin and Prodrug Mipsagargin and its ability to Stabilize cancer patients.

https://biosignaling.biomedcentral.com/articles/10.1186/s12964-019-0499-z

"Moreover, one prodrug has reached the stage of clinical phase II trials, where it recently was demonstrated to promote prolonged disease stabilization in patients with advanced hepatocellular carcinoma [59]"